Plant-derived molecules, genetic manipulation point to future chemoprevention methods

BOSTON -- Scientists are using genetic studies and natural chemicals, such as plant-derived triterpenoids, to further our knowledge on how genetic and early molecular interactions can lead to cancer, and how those early interactions can be manipulated to stave off a variety of cancers. The latest studies with new and promising chemopreventive agents were presented at the American Association for Cancer Research's Frontiers in Cancer Prevention Research meeting today.

Trterpenoids and the rexinoid LG100268 prevent lung tumors induced by vinyl carbamate in strain A/J mice

New synthetic drugs called triterpenoids which owe their origins to plant molecules have demonstrated their effectiveness in slowing the growth of lung cancer tumors, a research team from Dartmouth University has found.

Following up on previous work showing strong links between inflammation and the development of cancer, Karen Liby, Ph.D., a postdoctoral fellow, and her colleagues found that the triterpenoid CDDO-MA, currently undergoing trails for leukemia and solid tumors (sponsored by Reata Pharmaceuticals), significantly reduced the number and sizes of tumors in mice. In addition, a chemically related drug developed by Ligand Pharmaceuticals called LG100268 was effective at preventing tumor growth.

"Lung cancer is the leading cause of cancer deaths in the United States," said Liby. "Since the mortality from this disease is significant, and prognoses are poor once a patient has been diagnosed, prevention may provide the only avenues to combat this particular cancer. We think this study shows a promising role for triterpenoids and the drug LG100268 in stopping lung tumor growth."

The scientists knew that the compounds had anti-inflammatory properties and that LG100268 in particular could stop certain types of breast cancer in animal models. The compounds inhibited inflammation in a number of ways: halting nitric oxide production, blocking cyclo

Contact: Warren Froelich
American Association for Cancer Research

Page: 1 2 3 4 5

Related biology news :

1. Plant-derived vaccines safeguard against deadly plague
2. New nanotechnology able to examine single molecules, aiding in determining gene expression
3. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
4. Does the desire to consume alcohol and tobacco come from our genetic makeup?
5. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
6. Penn researchers discover pathway that eliminates genetic defects in red blood cells
7. Identifying the mechanism behind a genetic susceptibility to type 2 diabetes
8. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
9. Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder
10. Identified main genetic variants involved in response to HIV
11. Restless legs genetics on the move

Post Your Comments:

(Date:10/12/2015)... 2015 Hoyos Labs ... company, will introduce its new biometric four-finger ... simultaneously, providing an unprecedented level of security ... the new biometric standard for secure transactions ... from financial services to healthcare are implementing ...
(Date:10/9/2015)... , Oct. 09 2015 ... addition of the "Samsung Galaxy S6 ... report to their offering. --> ... the "Samsung Galaxy S6 Fingerprint Sensor ... their offering. --> Research and ...
(Date:10/8/2015)... October 8, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... Wocket® smart wallet announces that revenues for the ... $410,000 compared with $113,00 for the three months ... months ended September 30, 2015 were approximately $520,000. ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... CAMBRIDGE, Mass. , Oct. 13, 2015 ... quantitative methodologies at critical decision points throughout the drug ... at QSP Congress Boston 2015 on October 20-22, 2015 ... John Burke , PhD, Co-Founder, President, and CEO of ... drug discovery from early research to clinical trials" on ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... antibodies, today announced that it has received a Phase I Small Business Innovative ... the National Institute of General Medical Sciences (NIGMS), will fund the development of ...
(Date:10/13/2015)... Florida , October 13, 2015 ... specializing in the development of innovative peptide and gene-based ... metastatic disease, will be a featured presenting company at ... at the Wyndham Grand Hotel in Jupiter, ... TapImmune, Inc. (TPIV), a clinical-stage immunotherapy company ...
(Date:10/13/2015)... Hills, MI (PRWEB) , ... October 13, 2015 ... ... Michigan-based manufacturer and distributor of automation systems, material handling solutions and components, is ... Located off I-94 near State Street, the facility is Exotic’s second major expansion ...
Breaking Biology Technology:
Cached News: